Abstract
Background: Leptin is a protein hormone produced predominantly by adipocytes that plays a role in food intake regulation and a series of other physiological processes including blood pressure regulation.
Objectives: The aim of our study was to compare serum leptin levels in patients with primary hyperaldosteronism (PA) with those of healthy subjects and to explore the relationship of serum leptin levels and the parameters of insulin action in these patients before and after surgical or pharmacological treatment.
Methods: Serum potassium, leptin, aldosterone, insulin levels and plasma renin activity were measured and hyperinsulinaemic euglycaemic clamp was performed in 11 patients with PA and 11 healthy age-, gender- and body mass index (BMI)-matched subjects. In eight of 11 patients the same measurements were repeated at least 6 months after surgical or pharmacological treatment.
Results: The basal serum leptin levels in PA patients did not significantly differ from those of healthy subjects (mean ± s.e.m. 8.4 ± 1.9 vs 11.2 ± 1.8 ng/ml, P = 0.30), although their insulin sensitivity was significantly impaired (PA patients vs control subjects: glucose disposal rate in the last 20 min of clamp (M) 18.7 ± 1.8 vs30.6 ± 3.3 μmol/kg/min, metabolic clearance rate of glucose (MCRg) 3.9 ± 0.5 vs7.2 ± 1.1 ml/kg/min, P < 0.05). The surgical or pharmacological treatment of PA patients increased significantly their serum leptin levels (10.9 ± 3.7 vs 8.4 ± 1.9 ng/ml, P < 0.05) and simultaneously improved their insulin sensitivity. Basal serum leptin levels in both groups correlated positively with BMI and serum insulin levels. The inverse relationship between serum leptin levels and the insulin sensitivity parameters was found in both PA patients before treatment and healthy subjects. These relationships disappeared after treatment of PA patients except for those between serum leptin levels and MCRg.
Conclusion: Basal serum leptin levels in untreated patients with PA do not significantly differ from those of healthy subjects, but increase significantly after surgical or pharmacological treatment. The increase in serum leptin levels is paradoxically accompanied by the improvement of insulin sensitivity in these patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Zhang Y et al. Positional cloning of the mouse obese gene and its human homologue Nature 1994 372: 425–432
Haluzik M et al. Lower serum leptin concentrations in rugby players in comparison with healthy non sporting controls, relationships to anthropometric and biochemical parameters Eur J Appl Physiol 1998 79: 58–61
Haluzík M, Papežová H, Nedvídková J, Kábrt J . Serum leptin levels inpatients with anorexia nervosa before and after partial refeeding, relationships to serum lipids and biochemical nutritional parameters Phys Res 1999 48: 197–202
Dagogo-Jack S . Regulation and possible significance of leptin in humans: leptin in health and disease Diab Rev 1999 7: 23–38
Sierra-Honigmann MR et al. Biological action of leptin as an angiogenic factor Science 1998 281: 1683–1686
Hardie L, Trayhurn P, Abramovich D, Fowler P . Circulating leptin in women: a longitudinal study in the menstrual cycle and during pregnancy Clin Endocrinol 1997 47: 101–106
Cioffi JA et al. Novel B219/OB receptor isoforms: Possible role of leptin in hematopoiesis and reproduction Nat Med 1996 2: 585–589
Zemel MB . Insulin resistance, obesity and hypertension: an overview J Nutr 1995 125: 1715–1717
Haynes WG et al. Receptor-mediated regional sympathetic nerve activation by leptin J Clin Invest 1997 100: 270–278
Shek EW, Brands MW, Hall JE . Chronic leptin infusion increases arterial pressure Hypertension 1998 31: 409–414
Kokot F, Adamczak M, Wiecek A, Cieplok J . Does leptin play a role in the pathogenesis of essential hypertension? Kidney Blood Press Res 1999 22: 154–160
Sheu WH, Lee WJ, Chen YT . High plasma leptin concentrations in hypertensive men but not in hypertensive women J Hypertens 1999 17: 1289–1295
Uckaya G et al. Plasma leptin levels strongly correlate with plasma renin activity inpatients with essential hypertension Horm Metab Res 1999 31: 435–438
Shamiss A, Caroll J, Rosenthal T . Insulin resistance in secondary hypertension Am J Hypertens 1992 5: 26–28
Shimamoto K et al. Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism? J Hum Hypertens 1994 8: 755–759
Ishimori M et al. Increased insulin sensitivity inpatients with aldosterone-producing adenoma Clin Endocrinol 1994 41: 433–438
Šindelka G et al. Insulin action in primary hyperaldosteronism before and after surgical or pharamacological treatment Exp Clin Endocrinol Diab 2000 108: 21–25
Torpy DJ et al. Leptin levels are supressed in primary hyperaldosteronism Horm Metab Res 1999 31: 533–536
Fogt EJ, Dodd LM, Jenning EM, Clemerns AH . Development and evaluation of a glucose analyser for a glucose-controlled insulin infusion system Clin Chem 1978 24: 1366–1372
Coleman RA, Herrmann TS . Nutritional regulation of leptin in humans Diabetologia 1999 42: 639–646
Frühbeck G, Salvador J . Relation between leptin and the regulation of glucose metabolism Diabetologia 2000 43: 3–12
Acknowledgements
This study is supported by grants from IGA MH No. 5455-3, 5031-3, 6663-3, 6669-3 and Research Project of Ministry of Education No. J13/98:111100002-1. We thank Bio Vendor company for kindly providing ELISA kits for leptin measurements.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Haluzík, M., Šindelka, G., Widimský Jr, J. et al. Serum leptin levels in patients with primary hyperaldosteronism before and after treatment: relationships to insulin sensitivity. J Hum Hypertens 16, 41–45 (2002). https://doi.org/10.1038/sj.jhh.1001292
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001292
Keywords
This article is cited by
-
Secondary diabetes mellitus due to primary aldosteronism
Endocrine (2022)
-
Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis
Irish Journal of Medical Science (2014)
-
Marine natural product des-O-methyllasiodiplodin effectively lowers the blood glucose level in db/db mice via ameliorating inflammation
Acta Pharmacologica Sinica (2013)
-
The metabolic syndrome in primary aldosteronism
Current Diabetes Reports (2008)
-
The metabolic syndrome in primary aldosteronism
Current Hypertension Reports (2007)